4
项与 4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera) 相关的临床试验Multicenter, Double-blind, Comparative, Randomized Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra Inactivated Vaccine in Volunteers Aged 60 Years and Above
Comparative assessment of the tolerability, safety, and immunogenicity of the FLU-M® Tetra quadrivalent inactivated split influenza vaccine and the Ultrix® vaccine in volunteers aged 60 years and above.
Randomized, Double-blind, Comparative, Controlled Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old
Comparative trial of tolerability, reactogenicity, safety and immunogenicity of the Flu-M vaccine as compared to the Vaxigrip® vaccine in terms of prevention of influenza in children aged 6 months to 9 years (at the time of the first vaccination).
Multicenter, Double-blind, Comparative, Randomized Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years
Comparative assessment of the tolerability, safety, and immunogenicity of the Flu-M® Inactivated Split Influenza Vaccine (without preservative) and the Flu-M® vaccine (with preservative) in volunteers aged between 18 and 60
100 项与 4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera) 相关的临床结果
100 项与 4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera) 相关的转化医学
100 项与 4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera) 相关的专利（医药）
100 项与 4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera) 相关的药物交易
